Please assess the completion status of the following clinical trial:

Trial Title: The Ward Study for SeptiCyte® Lab to Distinguish Between Infection-positive and Infection-negative SIRS

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: OTHER
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~1. 18-89 years old on the day of enrollment.~2. Currently admitted to study designated medical or surgical ward~3. Have a clinical suspicion of sepsis as determined by two physicians after identification by hospital screening tool.~4. Screened positive for sepsis, severe sepsis or septic shock using the RISE2 screening tool.~5. Completed SBAR handover (Situation, Background, Assessment, Recommendation)~6. SIRS present as defined by the presence of two or more of the following:~   * Temperature \> 38°C or \< 36°C~  * Heart Rate \> 90 beat/min~  * Tachypnea \> 20/min or PaCO2 \< 32 mmHg~  * WBC count \> 12 000/mm3 or \< 4 000/mm3 or \> 10% immature neutrophils (bands)~Exclusion Criteria:~1. Consent not provided~2. Patients less than 18 years of age, or 90 years of age or older.~3. Patients for which a blood sample could not be taken within 24 hours of a physician first determining a clinical suspicion of sepsis.~4. Patients that are not located in the designated medical or surgical ward associated with the study.~5. Patients listed for Comfort Measures Only.~6. Less than 2 SIRS criteria~7. Commencement of narrow spectrum directed antibiotics prior to screening.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 89 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).